+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Mycosis Fungoides Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767873
  • Report
  • April 2019
  • Region: Global
  • 141 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Amgen Inc
  • Celgene Corp
  • Eisai Co Ltd
  • Johnson & Johnson
  • Kirin Holdings Co Ltd
  • Merck & Co Inc
  • MORE
The global clinical trial report- “2019 Mycosis Fungoides Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Mycosis Fungoides. It presents in-depth analysis of Mycosis Fungoides clinical trials across markets and companies. The research work is for providing complete understanding into trends in Mycosis Fungoides.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Mycosis Fungoides clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Mycosis Fungoides

The research work is prepared through extensive and continuous research on Mycosis Fungoides trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Mycosis Fungoides patients are identified
  • The report includes panorama of Mycosis Fungoides clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Mycosis Fungoides clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Amgen Inc
  • Celgene Corp
  • Eisai Co Ltd
  • Johnson & Johnson
  • Kirin Holdings Co Ltd
  • Merck & Co Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Mycosis Fungoides Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Mycosis Fungoides Clinical Trials by Region
2.2.2 Average Enrollment of Mycosis Fungoides Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Mycosis Fungoides Treatment, 2019

3. Region wise Mycosis Fungoides Clinical Trials
3.1 Asia Pacific Mycosis Fungoides Clinical Trials by Country
3.2 Europe Mycosis Fungoides Clinical Trials by Country
3.3 North America Mycosis Fungoides Clinical Trials by Country
3.4 Middle East and Africa Mycosis Fungoides Clinical Trials by Country
3.5 South and Central America Mycosis Fungoides Clinical Trials by Country

4. Mycosis Fungoides Clinical Trial Trends
4.1 Start Year wise Mycosis Fungoides Clinical Trials
4.2 Phase wise Mycosis Fungoides Clinical Trials
4.3 Trial Status wise Mycosis Fungoides Clinical Trials
4.4 Trial Type wise Mycosis Fungoides Clinical Trials

5. Mycosis Fungoides Average Enrollment Trends
5.1 Average Enrollment in Mycosis Fungoides Trials by Year
5.2 Average Enrollment in Mycosis Fungoides Trials by Phase
5.3 Average Enrollment in Mycosis Fungoides Trials by Status
5.4 Average Enrollment in Mycosis Fungoides Trials by Type of Trial

6. Companies Participating in Mycosis Fungoides Clinical Trials
6.1 Mycosis Fungoides Trials by Sponsor Type
6.2 Mycosis Fungoides Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Mycosis Fungoides Trials- Phase 1
7.2 Mycosis Fungoides Trials- Phase 2
7.3 Mycosis Fungoides Trials- Phase 3
7.4 Mycosis Fungoides Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Mycosis Fungoides Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Mycosis Fungoides Clinical Trials and Enrolment
Figure 5: Europe - Country wise Mycosis Fungoides Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Mycosis Fungoides Clinical Trials and Enrolment
Figure 7: North America - Country wise Mycosis Fungoides Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Mycosis Fungoides Clinical Trials and Enrolment
Figure 9: Mycosis Fungoides Clinical Trials by Phase
Figure 10: Mycosis Fungoides Clinical Trials by Trial Status
Figure 11: Mycosis Fungoides Clinical Trials by Type
Figure 12: Mycosis Fungoides Clinical Trials by Sponsor Type
Figure 13: Mycosis Fungoides Clinical Trials by Leading Sponsors
Figure 14: Mycosis Fungoides Average Enrollment by Phase
Figure 15: Mycosis Fungoides Average Enrollment by Trial Status
Figure 16: Mycosis Fungoides Average Enrollment by Type
Figure 17: Mycosis Fungoides- Average Enrolment by Type of Sponsors
Figure 18: Mycosis Fungoides- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Mycosis Fungoides Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Mycosis Fungoides Clinical Trials and Enrolment
Table 5: Europe - Country wise Mycosis Fungoides Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Mycosis Fungoides Clinical Trials and Enrolment
Table 7: North America - Country wise Mycosis Fungoides Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Mycosis Fungoides Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Mycosis Fungoides Average Enrollment by Phase
Table 15: Mycosis Fungoides Average Enrollment by Trial Status
Table 16: Mycosis Fungoides Average Enrollment by Type
Table 17: Mycosis Fungoides- Average Enrolment by Type of Sponsors
Table 18: Mycosis Fungoides- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3
  • Amgen Inc
  • Celgene Corp
  • Eisai Co Ltd
  • Johnson & Johnson
  • Kirin Holdings Co Ltd
  • Merck & Co Inc
  • Novartis AG
  • Pfizer Inc
  • Seattle Genetics Inc
  • Takeda Pharmaceutical Co Ltd
Note: Product cover images may vary from those shown
Adroll
adroll